182 results match your criteria: "Kirby Institute for Infection and Immunity in Society[Affiliation]"

Background: Chlamydia notifications continue to rise in young people in many countries and regular chlamydia testing is an important prevention strategy. Although there have been initiatives to increase testing in primary care, none have specifically investigated the role of practice nurses (PNs) in maximising testing rates. PNs have previously expressed a willingness to be involved, but noted lack of support from general practitioners (GPs) as a barrier.

View Article and Find Full Text PDF

Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries.

AIDS

January 2015

aDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio bDepartment of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA cDepartment of Pediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa dSchool of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA eSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa fInstitute of Social and Preventive Medicine, University of Bern, Switzerland gTumbi Regional Referral Hospital, Kibaha hMorogoro Regional Hospital, Morogoro, Tanzania iUniversity of New South Wales, The Kirby Institute for Infection and Immunity in Society, Darlinghurst, New South Wales, Australia jChiangrai Prachanukroh Hospital, Chiangrai, Thailand kInstitut de Santé Publique Epidemiologie et Développement, Université Bordeaux lInserm, Centre Inserm U897 'Epidémiologie et Biostatistique', Bordeaux, France mCentre National Hospitalier, Universitaire Hubert K. Maga, Cotonou, Bénin nRTI International, Biostatistics and Epidemiology, Research Triangle Park, North Carolina, USA.

Background: Viral load and CD4% are often not available in resource-limited settings for monitoring children's responses to antiretroviral therapy (ART). We aimed to construct normative curves for weight gain at 6, 12, 18, and 24 months following initiation of ART in children, and to assess the association between poor weight gain and subsequent responses to ART.

Design: Analysis of data from HIV-infected children younger than 10 years old from African and Asian clinics participating in the International epidemiologic Databases to Evaluate AIDS.

View Article and Find Full Text PDF

Unlabelled: Background This study aimed to describe sexual health behaviour, alcohol and other drug use, and health service use among young Noongar people in the south-west of Western Australia.

Method: A cross-sectional survey was undertaken among a sample of 244 Noongar people aged 16-30 years.

Results: The sample was more disadvantaged than the wider Noongar population.

View Article and Find Full Text PDF

Examining non-AIDS mortality among people who inject drugs.

AIDS

November 2014

aThe Kirby Institute for Infection and Immunity in Society, Faculty of Medicine bNational Drug and Alcohol Research Centre, University of New South Wales, Sydney cSchool of Population and Global Health, University of Melbourne, Melbourne, Australia.

Objective: To systematically review and analyse data from cohorts of people who inject drugs (PWID) to improve existing estimates of non-AIDS mortality used to calculate mortality among PWID in the Spectrum Estimates and Projection Package.

Design: Systematic review and meta-analysis.

Methods: We conducted an update of an earlier systematic review of mortality among PWID, searching specifically for studies providing data on non-AIDS-related deaths.

View Article and Find Full Text PDF

Background: Combination antiretroviral therapy (cART) effectively controls human immunodeficiency virus (HIV) infection but does not eliminate HIV, and lifelong treatment is therefore required. HIV-specific cytotoxic T lymphocyte (CTL) responses decline following cART initiation. Alterations in other HIV-specific immune responses that may assist in eliminating latent HIV infection, specifically antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent phagocytosis (ADP), are unclear.

View Article and Find Full Text PDF

Unlabelled: Background In HIV-positive people, sexually transmissible infections (STIs) probably increase the infectiousness of HIV.

Methods: In 2010, we established a cohort of individuals (n=554) from clinics in the Australian HIV Observational Database (AHOD). We calculated retrospective rates for four STIs for 2005-10 and prospective incidence rates for 2010-11.

View Article and Find Full Text PDF

This editorial to the special issue of Sexual Health on antiretroviral-based prevention of HIV infection is dedicated to showcasing research and practice in this area. It aims to promote debate regarding the potential of new antiretroviral-based prevention approaches and the challenges encountered in moving prevention innovations into the community. This special issue covers the breadth of innovative HIV prevention research, including that undertaken in the fields of epidemiology, clinical research, social and behavioural science, public health and policy analysis, and with special emphasis on Asia and the Pacific region.

View Article and Find Full Text PDF

Impaired Nef function is associated with early control of HIV-1 viremia.

J Virol

September 2014

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada

Unlabelled: Host and viral factors influence the HIV-1 infection course. Reduced Nef function has been observed in HIV-1 controllers during the chronic phase, but the kinetics and mechanisms of Nef attenuation in such individuals remain unclear. We examined plasma RNA-derived Nef clones from 10 recently infected individuals who subsequently suppressed viremia to less than 2,000 RNA copies/ml within 1 year postinfection (acute controllers) and 50 recently infected individuals who did not control viremia (acute progressors).

View Article and Find Full Text PDF

HIV-specific antibody-dependent phagocytosis matures during HIV infection.

Immunol Cell Biol

September 2014

Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.

Antibody-dependent phagocytosis (ADP) is a potentially important immune mechanism to clear HIV. How HIV-specific ADP responses mature during HIV infection or in response to vaccinations administered, including the partially successful RV144 HIV vaccine, is not known. We established a modified ADP assay to measure internalisation of HIV antibody (Ab)-opsonised targets using a specific hybridisation internalisation probe.

View Article and Find Full Text PDF

Reply to Paltiel et al.

Clin Infect Dis

July 2014

The Kirby Institute for Infection and Immunity in Society, The University of New South Wales, Darlinghurst, Australia.

View Article and Find Full Text PDF

Men who have sex with men (MSM) in Australia and overseas are disproportionately affected by sexually transmissible infections (STIs), including HIV. Many STIs are asymptomatic, so regular testing and management of asymptomatic MSM remains an important component of effective control. We reviewed articles from January 2009-May 2013 to inform the 2014 update of the 2010 Australian testing guidelines for asymptomatic MSM.

View Article and Find Full Text PDF

Objective: To describe the outcomes of antiretroviral therapy (ART) in a large cohort of HIV-infected children in Thailand.

Methods: The data were obtained from four collaborative referral sites around the country. Data from 2008 to March 2011 were collected prospectively, and data before 2008 were collected retrospectively.

View Article and Find Full Text PDF

Background: Antiretroviral therapy (ART) used as preexposure prophylaxis (PrEP) by human immunodeficiency virus (HIV)-seronegative individuals reduces the risk of acquiring HIV. However, the population-level impact and cost-effectiveness of using PrEP as a public health intervention remains debated.

Methods: We used a stochastic agent-based model of HIV transmission and progression to simulate the clinical and cost outcomes of different strategies of providing PrEP to men who have sex with men (MSM) in New South Wales (NSW), Australia.

View Article and Find Full Text PDF

Serious Non-AIDS events: Immunopathogenesis and interventional strategies.

AIDS Res Ther

December 2013

The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia.

Despite the major advances in the management of HIV infection, HIV-infected patients still have greater morbidity and mortality than the general population. Serious non-AIDS events (SNAEs), including non-AIDS malignancies, cardiovascular events, renal and hepatic disease, bone disorders and neurocognitive impairment, have become the major causes of morbidity and mortality in the antiretroviral therapy (ART) era. SNAEs occur at the rate of 1 to 2 per 100 person-years of follow-up.

View Article and Find Full Text PDF

Objectives: Despite antiretroviral therapy (ART), HIV-infected persons have increased risk of active tuberculosis (TB). PPD and combined ESAT-6 and CFP-10-specific-CD4 (EC-Sp-CD4) responses were examined over 96 weeks.

Methods: HIV-infected, ART-naive Thai adults with CD4 T cell count ≤350 cells/μL starting ART were assessed at baseline, wk4, 8, 12, 24, 48 and 96.

View Article and Find Full Text PDF

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.

Int J Drug Policy

January 2014

Burnet Institute, Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia.

Background: People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to investigate whether informing PWID of their HCV diagnosis was associated with a change in injecting behaviour.

View Article and Find Full Text PDF

Background & Aims: Despite advances in HCV treatment, recent data on treatment uptake is sparse. HCV treatment uptake and associated factors were evaluated in a community-based cohort in Vancouver, Canada.

Methods: The CHASE study is a cohort of inner city residents recruited from January 2003-June 2004.

View Article and Find Full Text PDF

Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men.

AIDS

September 2013

aCentre for Applied Medical Research, St Vincent's Hospital bThe Kirby Institute for Infection and Immunity in Society, University of New South Wales cWestern Sydney Sexual Health Centre, The University of Sydney & Westmead Hospital, Sydney, Australia. *Richard J. Hillman and Andrew Carr contributed equally to this article.

Objective: To quantify incidence of, and risk factors for, progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions (ASILs).

Design: Retrospective review of patients at St Vincent's Hospital Anal Cancer Screening Clinic during a period when high-grade ASILs were not routinely treated (2004-2011).

Methods: All patients who had an anal Papanicolaou smear or high-resolution anoscopy were included, except for patients with previous anal cancer.

View Article and Find Full Text PDF

Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.

PLoS One

June 2014

The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia ; HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.

Objectives: Restoration of Cytomegalovirus-specific-CD4 T cell (CMV-Sp-CD4) responses partly accounts for the reduction of CMV-disease with antiretroviral-therapy (ART), but CMV-Sp-CD4 may also drive immune activation and immunosenescence. This study characterized the dynamics of CMV-Sp-CD4 after ART initiation and explored associations with CD4 T cell recovery as well as frequency of naïve CD4 T cells at week 96.

Methods: Fifty HIV-infected, ART-naïve Thai adults with CD4 T cell count ≤ 350 cells/µL and starting ART were evaluated over 96 weeks (ClinicalTrials.

View Article and Find Full Text PDF

SPRING-2 the future of antiretroviral therapy.

Lancet Infect Dis

November 2013

The Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address:

View Article and Find Full Text PDF

Memory CD4(+) T lymphocytes in peripheral blood that express integrins α4ß7 preferentially recirculate through gut-associated lymphoid tissue (GALT), a proposed site of significant HIV-1 replication. Tregs and activated CD4(+) T cells in GALT could also be particularly susceptible to infection. We therefore hypothesized that infection of these subsets of memory CD4(+) T cells may contribute disproportionately to the HIV-1 reservoir.

View Article and Find Full Text PDF

Objective: To use existing evaluation data of community-based HIV prevention peer education workshops (PEWs) for gay men to explore the challenges in evaluating such programs in community settings.

Methods: Data came from 33 PEWs conducted with gay and bisexual men. A basic pre/post-test design was used to measure sexual health capacity.

View Article and Find Full Text PDF

Antiretroviral therapy: dolutegravir sets SAIL(ING).

Lancet

August 2013

The Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, NSW 2052, Australia.

View Article and Find Full Text PDF

Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.

Int J Infect Dis

October 2013

HIV-NAT, the Thai Red Cross AIDS Research Center, 104 Ratchadamri Road, Pathumwan, Bangkok, Thailand 10330; Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, Australia. Electronic address:

Background: There are limited data on treatment-related anemia in Asian HIV-infected children.

Methods: Data from Asian HIV-infected children aged <18 years on first-line highly active antiretroviral therapy (HAART) were used. Children who had pre-existing severe anemia at baseline were excluded.

View Article and Find Full Text PDF